PF4 and Thrombocytopenia: Pre-pandemic research on heparin-induced thrombocytopenia (HIT) showed that heparin, a polyanion, binds PF4, triggering anti-PF4-heparin antibodies that activate platelets, monocytes, neutrophils, and endothelial cells, leading to thrombocytopenia [33].